NC_000001.11:g.228149860A>G |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV000023738]|Spastic paraplegia [RCV000633051]|not provided [RCV001781305] |
Chr1:228149860 [GRCh38] Chr1:228337561 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic |
NM_020435.4(GJC2):c.989del (p.Pro330fs) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV000002154] |
Chr1:228158745 [GRCh38] Chr1:228346446 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.914_947del (p.Pro305fs) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV000002157]|not provided [RCV001781168] |
Chr1:228158659..228158692 [GRCh38] Chr1:228346360..228346393 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.695_696insG (p.Tyr232Ter) |
insertion |
Hypomyelinating leukodystrophy 2 [RCV000002158] |
Chr1:228158453..228158454 [GRCh38] Chr1:228346154..228346155 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.302G>A (p.Arg101His) |
single nucleotide variant |
not provided [RCV000522395] |
Chr1:228158060 [GRCh38] Chr1:228345761 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.857T>C (p.Met286Thr) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV000002152]|See cases [RCV002287318] |
Chr1:228158615 [GRCh38] Chr1:228346316 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.268C>T (p.Pro90Ser) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV000002153] |
Chr1:228158026 [GRCh38] Chr1:228345727 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic |
NM_020435.4(GJC2):c.718C>T (p.Arg240Ter) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV000002155]|not provided [RCV001723533] |
Chr1:228158476 [GRCh38] Chr1:228346177 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.814T>G (p.Tyr272Asp) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV000002156] |
Chr1:228158572 [GRCh38] Chr1:228346273 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.108C>G (p.Ile36Met) |
single nucleotide variant |
Hereditary spastic paraplegia 44 [RCV000002159] |
Chr1:228157866 [GRCh38] Chr1:228345567 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.143C>T (p.Ser48Leu) |
single nucleotide variant |
Lymphatic malformation 3 [RCV000002160] |
Chr1:228157901 [GRCh38] Chr1:228345602 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.778C>T (p.Arg260Cys) |
single nucleotide variant |
Lymphatic malformation 3 [RCV000002161] |
Chr1:228158536 [GRCh38] Chr1:228346237 [GRCh37] Chr1:1q42.13 |
pathogenic |
GRCh38/hg38 1q32.3-44(chr1:214023812-248918469)x3 |
copy number gain |
See cases [RCV000050981] |
Chr1:214023812..248918469 [GRCh38] Chr1:214197155..249212668 [GRCh37] Chr1:212263778..247179291 [NCBI36] Chr1:1q32.3-44 |
pathogenic |
GRCh38/hg38 1q41-44(chr1:223347693-248918469)x3 |
copy number gain |
See cases [RCV000050581] |
Chr1:223347693..248918469 [GRCh38] Chr1:223521035..249212668 [GRCh37] Chr1:221587658..247179291 [NCBI36] Chr1:1q41-44 |
pathogenic |
GRCh38/hg38 1q41-44(chr1:221902539-248918469)x3 |
copy number gain |
Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051875]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051875]|See cases [RCV000051875] |
Chr1:221902539..248918469 [GRCh38] Chr1:222075881..249212668 [GRCh37] Chr1:220142504..247179291 [NCBI36] Chr1:1q41-44 |
pathogenic |
GRCh38/hg38 1q41-44(chr1:223887780-248891309)x3 |
copy number gain |
See cases [RCV000051880] |
Chr1:223887780..248891309 [GRCh38] Chr1:224075482..249185508 [GRCh37] Chr1:222142105..247152131 [NCBI36] Chr1:1q41-44 |
pathogenic |
GRCh38/hg38 1q32.2-44(chr1:209646207-248931113)x3 |
copy number gain |
See cases [RCV000051861] |
Chr1:209646207..248931113 [GRCh38] Chr1:209819552..249225312 [GRCh37] Chr1:207886175..247191935 [NCBI36] Chr1:1q32.2-44 |
pathogenic |
GRCh38/hg38 1q42.11-44(chr1:224096488-248918469)x3 |
copy number gain |
See cases [RCV000051882] |
Chr1:224096488..248918469 [GRCh38] Chr1:224284190..249212668 [GRCh37] Chr1:222350813..247179291 [NCBI36] Chr1:1q42.11-44 |
pathogenic |
GRCh38/hg38 1q41-42.13(chr1:221519280-228862141)x1 |
copy number loss |
Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053955]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053955]|See cases [RCV000053955] |
Chr1:221519280..228862141 [GRCh38] Chr1:221692622..228997888 [GRCh37] Chr1:219759245..227064511 [NCBI36] Chr1:1q41-42.13 |
pathogenic |
NM_020435.4(GJC2):c.787G>A (p.Glu263Lys) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV000054496] |
Chr1:228158545 [GRCh38] Chr1:228346246 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.1241G>T (p.Arg414Leu) |
single nucleotide variant |
Spastic paraplegia [RCV001312683] |
Chr1:228158999 [GRCh38] Chr1:228346700 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.550G>A (p.Ala184Thr) |
single nucleotide variant |
Inborn genetic diseases [RCV002537958]|Spastic paraplegia [RCV003588734]|not provided [RCV001810563]|not specified [RCV003994251] |
Chr1:228158308 [GRCh38] Chr1:228346009 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.78del (p.Trp27fs) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV000256421] |
Chr1:228157836 [GRCh38] Chr1:228345537 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
GRCh38/hg38 1q32.2-44(chr1:209963625-248918469)x3 |
copy number gain |
See cases [RCV000134979] |
Chr1:209963625..248918469 [GRCh38] Chr1:210136970..249212668 [GRCh37] Chr1:208203593..247179291 [NCBI36] Chr1:1q32.2-44 |
pathogenic |
GRCh38/hg38 1q42.13(chr1:227613596-229249335)x4 |
copy number gain |
See cases [RCV000134940] |
Chr1:227613596..229249335 [GRCh38] Chr1:227801297..229385082 [GRCh37] Chr1:225867920..227451705 [NCBI36] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
GRCh38/hg38 1q41-44(chr1:223815147-248918469)x3 |
copy number gain |
See cases [RCV000135839] |
Chr1:223815147..248918469 [GRCh38] Chr1:224002849..249212668 [GRCh37] Chr1:222069472..247179291 [NCBI36] Chr1:1q41-44 |
pathogenic |
GRCh38/hg38 1q42.12-42.2(chr1:226185124-232872488)x1 |
copy number loss |
See cases [RCV000135796] |
Chr1:226185124..232872488 [GRCh38] Chr1:226372825..233008234 [GRCh37] Chr1:224439448..231074857 [NCBI36] Chr1:1q42.12-42.2 |
pathogenic |
GRCh38/hg38 1q41-42.13(chr1:223347693-228556332)x1 |
copy number loss |
See cases [RCV000136636] |
Chr1:223347693..228556332 [GRCh38] Chr1:223521035..228744033 [GRCh37] Chr1:221587658..226810656 [NCBI36] Chr1:1q41-42.13 |
pathogenic |
GRCh38/hg38 1q42.11-44(chr1:224022862-248918469)x3 |
copy number gain |
See cases [RCV000137769] |
Chr1:224022862..248918469 [GRCh38] Chr1:224210564..249212668 [GRCh37] Chr1:222277187..247179291 [NCBI36] Chr1:1q42.11-44 |
pathogenic |
GRCh38/hg38 1q42.12-44(chr1:225438480-248787200)x3 |
copy number gain |
See cases [RCV000142448] |
Chr1:225438480..248787200 [GRCh38] Chr1:225626182..249060210 [GRCh37] Chr1:223692805..247048022 [NCBI36] Chr1:1q42.12-44 |
pathogenic |
GRCh38/hg38 1q42.12-42.13(chr1:225382172-230418801)x1 |
copy number loss |
See cases [RCV000143223] |
Chr1:225382172..230418801 [GRCh38] Chr1:225569874..230554547 [GRCh37] Chr1:223636497..228621170 [NCBI36] Chr1:1q42.12-42.13 |
pathogenic |
GRCh38/hg38 1q32.2-44(chr1:207346642-248930485)x3 |
copy number gain |
See cases [RCV000143727] |
Chr1:207346642..248930485 [GRCh38] Chr1:207519987..249224684 [GRCh37] Chr1:205586610..247191307 [NCBI36] Chr1:1q32.2-44 |
pathogenic |
GRCh37/hg19 1q31.3-42.13(chr1:197811907-228997888)x3 |
copy number gain |
See cases [RCV000240137] |
Chr1:197811907..228997888 [GRCh37] Chr1:1q31.3-42.13 |
pathogenic |
GRCh38/hg38 1q42.13(chr1:228148416-228372055)x1 |
copy number loss |
Breast ductal adenocarcinoma [RCV000207146] |
Chr1:228148416..228372055 [GRCh38] Chr1:228336115..228559754 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.17G>A (p.Trp6Ter) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV004691112]|not provided [RCV000224295] |
Chr1:228157775 [GRCh38] Chr1:228345476 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic |
NM_020435.4(GJC2):c.947C>T (p.Pro316Leu) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001847952]|Spastic paraplegia [RCV001086089]|not provided [RCV000224481] |
Chr1:228158705 [GRCh38] Chr1:228346406 [GRCh37] Chr1:1q42.13 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_020435.4(GJC2):c.108C>T (p.Ile36=) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001847953]|Hypomyelinating leukodystrophy 2 [RCV002500753]|Spastic paraplegia [RCV001086772]|not provided [RCV000224514]|not specified [RCV000615150] |
Chr1:228157866 [GRCh38] Chr1:228345567 [GRCh37] Chr1:1q42.13 |
benign|likely benign |
NM_020435.4(GJC2):c.594C>T (p.His198=) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001848002]|Spastic paraplegia [RCV000231958]|not provided [RCV004713427]|not specified [RCV000243151] |
Chr1:228158352 [GRCh38] Chr1:228346053 [GRCh37] Chr1:1q42.13 |
benign |
NM_020435.4(GJC2):c.1193C>T (p.Thr398Ile) |
single nucleotide variant |
GJC2-related disorder [RCV003939882]|Hereditary spastic paraplegia [RCV001848000]|Spastic paraplegia [RCV001084409]|not provided [RCV000436644]|not specified [RCV004800355] |
Chr1:228158951 [GRCh38] Chr1:228346652 [GRCh37] Chr1:1q42.13 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_020435.4(GJC2):c.454GAG[8] (p.Glu158dup) |
microsatellite |
Hereditary spastic paraplegia [RCV001848001]|Spastic paraplegia [RCV000229105] |
Chr1:228158211..228158212 [GRCh38] Chr1:228345912..228345913 [GRCh37] Chr1:1q42.13 |
uncertain significance |
GRCh37/hg19 1q42.12-42.13(chr1:226871745-229906954)x1 |
copy number loss |
See cases [RCV000240001] |
Chr1:226871745..229906954 [GRCh37] Chr1:1q42.12-42.13 |
uncertain significance |
NM_020435.4(GJC2):c.147C>T (p.Asp49=) |
single nucleotide variant |
Spastic paraplegia [RCV000556865]|not specified [RCV000250957] |
Chr1:228157905 [GRCh38] Chr1:228345606 [GRCh37] Chr1:1q42.13 |
benign|likely benign |
NM_020435.4(GJC2):c.966G>C (p.Ala322=) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001848037]|Spastic paraplegia [RCV001516747]|not provided [RCV004714600]|not specified [RCV000247903] |
Chr1:228158724 [GRCh38] Chr1:228346425 [GRCh37] Chr1:1q42.13 |
benign |
NM_020435.4(GJC2):c.970_971dup (p.Ala325fs) |
duplication |
Abnormality of the nervous system [RCV001814162]|Hypomyelinating leukodystrophy 2 [RCV002250639]|not provided [RCV000489273] |
Chr1:228158727..228158728 [GRCh38] Chr1:228346428..228346429 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic |
NM_020435.4(GJC2):c.679T>A (p.Phe227Ile) |
single nucleotide variant |
Inborn genetic diseases [RCV000624897]|not provided [RCV005223076] |
Chr1:228158437 [GRCh38] Chr1:228346138 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.-19-3C>A |
single nucleotide variant |
not provided [RCV000599076] |
Chr1:228157737 [GRCh38] Chr1:228345438 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.83T>C (p.Leu28Pro) |
single nucleotide variant |
Inborn genetic diseases [RCV000623747]|not provided [RCV002263835] |
Chr1:228157841 [GRCh38] Chr1:228345542 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.528G>A (p.Glu176=) |
single nucleotide variant |
Spastic paraplegia [RCV000535321] |
Chr1:228158286 [GRCh38] Chr1:228345987 [GRCh37] Chr1:1q42.13 |
benign |
NM_020435.4(GJC2):c.739_740delinsTC (p.Arg247Ser) |
indel |
not provided [RCV000413087] |
Chr1:228158497..228158498 [GRCh38] Chr1:228346198..228346199 [GRCh37] Chr1:1q42.13 |
uncertain significance |
GRCh37/hg19 1q31.3-44(chr1:195483439-249213000)x3 |
copy number gain |
See cases [RCV000449172] |
Chr1:195483439..249213000 [GRCh37] Chr1:1q31.3-44 |
pathogenic |
GRCh37/hg19 1q41-44(chr1:214697099-249224684)x3 |
copy number gain |
See cases [RCV000449210] |
Chr1:214697099..249224684 [GRCh37] Chr1:1q41-44 |
pathogenic |
NM_020435.4(GJC2):c.417C>A (p.Ala139=) |
single nucleotide variant |
Spastic paraplegia [RCV001861574]|not provided [RCV003418124]|not specified [RCV000441940] |
Chr1:228158175 [GRCh38] Chr1:228345876 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NM_020435.4(GJC2):c.791A>G (p.Lys264Arg) |
single nucleotide variant |
not provided [RCV000422922] |
Chr1:228158549 [GRCh38] Chr1:228346250 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.740G>C (p.Arg247Pro) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV004691230]|Spastic paraplegia [RCV003766427]|not provided [RCV000440284] |
Chr1:228158498 [GRCh38] Chr1:228346199 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.739C>T (p.Arg247Cys) |
single nucleotide variant |
Spastic paraplegia [RCV001851074]|not provided [RCV000430054] |
Chr1:228158497 [GRCh38] Chr1:228346198 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.-14G>C |
single nucleotide variant |
not specified [RCV000454827] |
Chr1:228157745 [GRCh38] Chr1:228345446 [GRCh37] Chr1:1q42.13 |
benign |
NM_020435.4(GJC2):c.310del (p.Arg104fs) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV004698342]|not provided [RCV000483649] |
Chr1:228158066 [GRCh38] Chr1:228345767 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic |
NM_020435.4(GJC2):c.-6G>C |
single nucleotide variant |
not provided [RCV001653795]|not specified [RCV000455508] |
Chr1:228157753 [GRCh38] Chr1:228345454 [GRCh37] Chr1:1q42.13 |
benign |
NM_020435.4(GJC2):c.362_398del (p.Arg121fs) |
deletion |
not provided [RCV000484973] |
Chr1:228158119..228158155 [GRCh38] Chr1:228345820..228345856 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.433G>A (p.Glu145Lys) |
single nucleotide variant |
not provided [RCV000486395] |
Chr1:228158191 [GRCh38] Chr1:228345892 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.575del (p.Pro192fs) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV004691239]|not provided [RCV000486680] |
Chr1:228158330 [GRCh38] Chr1:228346031 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684)x3 |
copy number gain |
See cases [RCV000510383] |
Chr1:849467..249224684 [GRCh37] Chr1:1p36.33-q44 |
pathogenic |
NM_020435.4(GJC2):c.1175C>G (p.Ser392Cys) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV000504277] |
Chr1:228158933 [GRCh38] Chr1:228346634 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.1254_1258delinsCG (p.Lys418_Arg420delinsAsnGly) |
indel |
Hereditary spastic paraplegia 44 [RCV000509408] |
Chr1:228159012..228159016 [GRCh38] Chr1:228346713..228346717 [GRCh37] Chr1:1q42.13 |
not provided |
NM_020435.4(GJC2):c.575C>G (p.Pro192Arg) |
single nucleotide variant |
GJC2-related disorder [RCV003942608]|Spastic paraplegia [RCV001089177]|not provided [RCV000493519] |
Chr1:228158333 [GRCh38] Chr1:228346034 [GRCh37] Chr1:1q42.13 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
GRCh37/hg19 1q42.11-44(chr1:224105294-249224684)x3 |
copy number gain |
See cases [RCV000510981] |
Chr1:224105294..249224684 [GRCh37] Chr1:1q42.11-44 |
pathogenic |
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684) |
copy number gain |
See cases [RCV000510926] |
Chr1:849467..249224684 [GRCh37] Chr1:1p36.33-q44 |
pathogenic |
NM_020435.4(GJC2):c.970G>A (p.Ala324Thr) |
single nucleotide variant |
not provided [RCV000514454] |
Chr1:228158728 [GRCh38] Chr1:228346429 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.845A>G (p.Asn282Ser) |
single nucleotide variant |
Spastic paraplegia [RCV000633033] |
Chr1:228158603 [GRCh38] Chr1:228346304 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1102G>A (p.Asp368Asn) |
single nucleotide variant |
Spastic paraplegia [RCV000633020] |
Chr1:228158860 [GRCh38] Chr1:228346561 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.80G>A (p.Trp27Ter) |
single nucleotide variant |
Inborn genetic diseases [RCV000622713] |
Chr1:228157838 [GRCh38] Chr1:228345539 [GRCh37] Chr1:1q42.13 |
pathogenic |
GRCh37/hg19 1q41-44(chr1:218252551-249224684)x3 |
copy number gain |
not provided [RCV000684700] |
Chr1:218252551..249224684 [GRCh37] Chr1:1q41-44 |
pathogenic |
GRCh37/hg19 1q42.13(chr1:227696109-229152386)x3 |
copy number gain |
not provided [RCV000684706] |
Chr1:227696109..229152386 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.448C>G (p.Leu150Val) |
single nucleotide variant |
Spastic paraplegia [RCV000702728] |
Chr1:228158206 [GRCh38] Chr1:228345907 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1082G>T (p.Gly361Val) |
single nucleotide variant |
Inborn genetic diseases [RCV004629297]|Spastic paraplegia [RCV000689259] |
Chr1:228158840 [GRCh38] Chr1:228346541 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.85_86dup (p.Val30fs) |
duplication |
Spastic paraplegia [RCV000692464] |
Chr1:228157841..228157842 [GRCh38] Chr1:228345542..228345543 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic |
GRCh37/hg19 1p36.33-q44(chr1:47851-249228449)x3 |
copy number gain |
not provided [RCV000736295] |
Chr1:47851..249228449 [GRCh37] Chr1:1p36.33-q44 |
pathogenic |
GRCh37/hg19 1p36.33-q44(chr1:82154-249218992)x3 |
copy number gain |
not provided [RCV000736305] |
Chr1:82154..249218992 [GRCh37] Chr1:1p36.33-q44 |
pathogenic |
GRCh37/hg19 1q42.13(chr1:228260287-228617063)x1 |
copy number loss |
not provided [RCV000736887] |
Chr1:228260287..228617063 [GRCh37] Chr1:1q42.13 |
benign |
GRCh37/hg19 1q42.13(chr1:228336130-228402121)x3 |
copy number gain |
not provided [RCV000736888] |
Chr1:228336130..228402121 [GRCh37] Chr1:1q42.13 |
benign |
GRCh37/hg19 1q42.13(chr1:228336130-228404818)x3 |
copy number gain |
not provided [RCV000736889] |
Chr1:228336130..228404818 [GRCh37] Chr1:1q42.13 |
benign |
NM_020435.4(GJC2):c.-20G>C |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV004577340] |
Chr1:228150007 [GRCh38] Chr1:228337708 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1030C>T (p.Arg344Trp) |
single nucleotide variant |
not provided [RCV000994275] |
Chr1:228158788 [GRCh38] Chr1:228346489 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.768C>G (p.Cys256Trp) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV000984491] |
Chr1:228158526 [GRCh38] Chr1:228346227 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.418G>A (p.Asp140Asn) |
single nucleotide variant |
Inborn genetic diseases [RCV003160307]|Spastic paraplegia [RCV001043415] |
Chr1:228158176 [GRCh38] Chr1:228345877 [GRCh37] Chr1:1q42.13 |
uncertain significance |
GRCh37/hg19 1q42.13(chr1:228297613-228703236) |
copy number gain |
Aortic valve disease 1 [RCV000770940] |
Chr1:228297613..228703236 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.599G>A (p.Gly200Glu) |
single nucleotide variant |
Spastic paraplegia [RCV000806599] |
Chr1:228158357 [GRCh38] Chr1:228346058 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.556G>T (p.Gly186Cys) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001849133]|Inborn genetic diseases [RCV002538896]|Spastic paraplegia [RCV000861006]|not provided [RCV002261233] |
Chr1:228158314 [GRCh38] Chr1:228346015 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NM_020435.4(GJC2):c.216G>T (p.Ala72=) |
single nucleotide variant |
Spastic paraplegia [RCV000865657] |
Chr1:228157974 [GRCh38] Chr1:228345675 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.817G>C (p.Val273Leu) |
single nucleotide variant |
Spastic paraplegia [RCV000820923] |
Chr1:228158575 [GRCh38] Chr1:228346276 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.697C>G (p.Leu233Val) |
single nucleotide variant |
Spastic paraplegia [RCV000805051] |
Chr1:228158455 [GRCh38] Chr1:228346156 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.466_467delinsAT (p.Glu156Met) |
indel |
Spastic paraplegia [RCV000798708] |
Chr1:228158224..228158225 [GRCh38] Chr1:228345925..228345926 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.331C>T (p.Arg111Cys) |
single nucleotide variant |
Spastic paraplegia [RCV000800618] |
Chr1:228158089 [GRCh38] Chr1:228345790 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1134_1144del (p.Ala379fs) |
deletion |
GJC2-related disorder [RCV004758054]|Hereditary spastic paraplegia 44 [RCV001335054]|Hypomyelinating leukodystrophy 2 [RCV000986563]|Spastic paraplegia [RCV000813174] |
Chr1:228158883..228158893 [GRCh38] Chr1:228346584..228346594 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic |
GRCh37/hg19 1q42.13(chr1:228235107-228983659)x3 |
copy number gain |
not provided [RCV000848102] |
Chr1:228235107..228983659 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.591dup (p.His198fs) |
duplication |
Pelizaeus-Merzbacher disease [RCV000790418]|Spastic paraplegia [RCV002536883] |
Chr1:228158347..228158348 [GRCh38] Chr1:228346048..228346049 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic |
NM_020435.4(GJC2):c.107del (p.Ile36fs) |
deletion |
Dystonic disorder [RCV001003945]|Hypomyelinating leukodystrophy 2 [RCV001824156]|Intellectual disability [RCV000850195]|Lymphatic malformation 3 [RCV003989597] |
Chr1:228157865 [GRCh38] Chr1:228345566 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.87G>A (p.Thr29=) |
single nucleotide variant |
Spastic paraplegia [RCV000797574] |
Chr1:228157845 [GRCh38] Chr1:228345546 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NM_020435.4(GJC2):c.595G>A (p.Asp199Asn) |
single nucleotide variant |
Spastic paraplegia [RCV000814129] |
Chr1:228158353 [GRCh38] Chr1:228346054 [GRCh37] Chr1:1q42.13 |
uncertain significance |
GRCh37/hg19 1q25.3-44(chr1:182388773-249111240)x3 |
copy number gain |
not provided [RCV000845852] |
Chr1:182388773..249111240 [GRCh37] Chr1:1q25.3-44 |
pathogenic |
NM_020435.4(GJC2):c.217C>A (p.Pro73Thr) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV000986561]|Spastic paraplegia [RCV002549670] |
Chr1:228157975 [GRCh38] Chr1:228345676 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.193_195del (p.Asn65del) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV001263460]|not specified [RCV000785005] |
Chr1:228157949..228157951 [GRCh38] Chr1:228345650..228345652 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.812T>G (p.Met271Arg) |
single nucleotide variant |
not provided [RCV003314971] |
Chr1:228158570 [GRCh38] Chr1:228346271 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.740G>A (p.Arg247His) |
single nucleotide variant |
Spastic paraplegia [RCV000808875] |
Chr1:228158498 [GRCh38] Chr1:228346199 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.-20+68C>T |
single nucleotide variant |
not provided [RCV001571643] |
Chr1:228150075 [GRCh38] Chr1:228337776 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1150C>T (p.Pro384Ser) |
single nucleotide variant |
Inborn genetic diseases [RCV002561879]|Spastic paraplegia [RCV001215968]|not provided [RCV003163659]|not specified [RCV004699205] |
Chr1:228158908 [GRCh38] Chr1:228346609 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NM_020435.4(GJC2):c.1293G>C (p.Arg431Ser) |
single nucleotide variant |
Spastic paraplegia [RCV001239434] |
Chr1:228159051 [GRCh38] Chr1:228346752 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.733T>A (p.Cys245Ser) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV001249464] |
Chr1:228158491 [GRCh38] Chr1:228346192 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.476C>T (p.Thr159Met) |
single nucleotide variant |
Spastic paraplegia [RCV001207201] |
Chr1:228158234 [GRCh38] Chr1:228345935 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.550G>T (p.Ala184Ser) |
single nucleotide variant |
not provided [RCV000994274] |
Chr1:228158308 [GRCh38] Chr1:228346009 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.647A>G (p.Gln216Arg) |
single nucleotide variant |
not provided [RCV003233442] |
Chr1:228158405 [GRCh38] Chr1:228346106 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1027G>T (p.Ala343Ser) |
single nucleotide variant |
Spastic paraplegia [RCV002573222]|not provided [RCV001573303] |
Chr1:228158785 [GRCh38] Chr1:228346486 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NM_020435.4(GJC2):c.445G>A (p.Gly149Ser) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV000986562]|Spastic paraplegia [RCV000861248] |
Chr1:228158203 [GRCh38] Chr1:228345904 [GRCh37] Chr1:1q42.13 |
benign|uncertain significance |
NM_020435.4(GJC2):c.1145G>A (p.Arg382Gln) |
single nucleotide variant |
Spastic paraplegia [RCV001208698] |
Chr1:228158903 [GRCh38] Chr1:228346604 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1155del (p.Arg386fs) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV000986564]|not provided [RCV004773213] |
Chr1:228158908 [GRCh38] Chr1:228346609 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.-10G>C |
single nucleotide variant |
not provided [RCV001530816] |
Chr1:228157749 [GRCh38] Chr1:228345450 [GRCh37] Chr1:1q42.13 |
benign |
NM_020435.4(GJC2):c.404G>A (p.Trp135Ter) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV004701242] |
Chr1:228158162 [GRCh38] Chr1:228345863 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.*93C>T |
single nucleotide variant |
not provided [RCV001649294] |
Chr1:228159171 [GRCh38] Chr1:228346872 [GRCh37] Chr1:1q42.13 |
benign |
NM_020435.4(GJC2):c.23_24delinsAA (p.Phe8Ter) |
indel |
not provided [RCV001008736] |
Chr1:228157781..228157782 [GRCh38] Chr1:228345482..228345483 [GRCh37] Chr1:1q42.13 |
pathogenic |
GRCh37/hg19 1q41-43(chr1:219916966-239004378)x3 |
copy number gain |
not provided [RCV001005175] |
Chr1:219916966..239004378 [GRCh37] Chr1:1q41-43 |
pathogenic |
NM_020435.4(GJC2):c.*5G>T |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001847311]|not provided [RCV001608725] |
Chr1:228159083 [GRCh38] Chr1:228346784 [GRCh37] Chr1:1q42.13 |
benign|likely benign |
NM_020435.4(GJC2):c.883C>T (p.Gln295Ter) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV001090093] |
Chr1:228158641 [GRCh38] Chr1:228346342 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.709T>G (p.Phe237Val) |
single nucleotide variant |
Intellectual disability [RCV001252004] |
Chr1:228158467 [GRCh38] Chr1:228346168 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.148G>T (p.Glu50Ter) |
single nucleotide variant |
not provided [RCV001093211] |
Chr1:228157906 [GRCh38] Chr1:228345607 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.1199C>A (p.Ala400Glu) |
single nucleotide variant |
Lymphatic malformation 3 [RCV001528127]|Spastic paraplegia [RCV001476328]|not provided [RCV001093212] |
Chr1:228158957 [GRCh38] Chr1:228346658 [GRCh37] Chr1:1q42.13 |
pathogenic|likely benign|uncertain significance |
NM_020435.4(GJC2):c.979T>C (p.Leu327=) |
single nucleotide variant |
not provided [RCV001813124] |
Chr1:228158737 [GRCh38] Chr1:228346438 [GRCh37] Chr1:1q42.13 |
likely benign |
GRCh37/hg19 1q32.1-44(chr1:204045948-249218992)x3 |
copy number gain |
See cases [RCV001007407] |
Chr1:204045948..249218992 [GRCh37] Chr1:1q32.1-44 |
pathogenic |
NM_020435.4(GJC2):c.*157G>A |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001847317]|not provided [RCV001667996] |
Chr1:228159235 [GRCh38] Chr1:228346936 [GRCh37] Chr1:1q42.13 |
benign|uncertain significance |
NM_020435.4(GJC2):c.219_220del (p.Leu74fs) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV001647229] |
Chr1:228157975..228157976 [GRCh38] Chr1:228345676..228345677 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.254T>C (p.Val85Ala) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV001647230] |
Chr1:228158012 [GRCh38] Chr1:228345713 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.302G>T (p.Arg101Leu) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV002298930]|Spastic ataxia [RCV001647154]|Spastic paraplegia [RCV002546241]|not provided [RCV004727148] |
Chr1:228158060 [GRCh38] Chr1:228345761 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.1240C>G (p.Arg414Gly) |
single nucleotide variant |
Inborn genetic diseases [RCV002554410]|Spastic paraplegia [RCV001058663] |
Chr1:228158998 [GRCh38] Chr1:228346699 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.436_462del (p.Pro146_Glu154del) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV001535700]|Spastic paraplegia [RCV001213825] |
Chr1:228158178..228158204 [GRCh38] Chr1:228345879..228345905 [GRCh37] Chr1:1q42.13 |
uncertain significance|not provided |
NM_020435.4(GJC2):c.1222C>T (p.Arg408Trp) |
single nucleotide variant |
Spastic paraplegia [RCV001047775] |
Chr1:228158980 [GRCh38] Chr1:228346681 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.364C>G (p.Arg122Gly) |
single nucleotide variant |
Spastic paraplegia [RCV001207717] |
Chr1:228158122 [GRCh38] Chr1:228345823 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.907_923del (p.Gly303fs) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV001200941] |
Chr1:228158661..228158677 [GRCh38] Chr1:228346362..228346378 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.550_566del (p.Ala184fs) |
deletion |
Hereditary spastic paraplegia 44 [RCV001196363] |
Chr1:228158304..228158320 [GRCh38] Chr1:228346005..228346021 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.118G>C (p.Ala40Pro) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV001249465] |
Chr1:228157876 [GRCh38] Chr1:228345577 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.377C>T (p.Ala126Val) |
single nucleotide variant |
not provided [RCV001663631] |
Chr1:228158135 [GRCh38] Chr1:228345836 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.62C>T (p.Thr21Ile) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV001261524] |
Chr1:228157820 [GRCh38] Chr1:228345521 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.575dup (p.Thr195fs) |
duplication |
Hypomyelinating leukodystrophy 2 [RCV001261412] |
Chr1:228158329..228158330 [GRCh38] Chr1:228346030..228346031 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.1096dup (p.Asp366fs) |
duplication |
Hypomyelinating leukodystrophy 2 [RCV001260245] |
Chr1:228158850..228158851 [GRCh38] Chr1:228346551..228346552 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.49dup (p.His17fs) |
duplication |
Hypomyelinating leukodystrophy 2 [RCV001263436] |
Chr1:228157805..228157806 [GRCh38] Chr1:228345506..228345507 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.907_923dup (p.Pro309fs) |
duplication |
Hypomyelinating leukodystrophy 2 [RCV004691702] |
Chr1:228158660..228158661 [GRCh38] Chr1:228346361..228346362 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.571_572insG (p.Thr191fs) |
insertion |
Hypomyelinating leukodystrophy 2 [RCV001260243] |
Chr1:228158329..228158330 [GRCh38] Chr1:228346030..228346031 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1093G>A (p.Gly365Arg) |
single nucleotide variant |
Spastic paraplegia [RCV001350767] |
Chr1:228158851 [GRCh38] Chr1:228346552 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.893_942del (p.Val298fs) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV004691700] |
Chr1:228158646..228158695 [GRCh38] Chr1:228346347..228346396 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.1254_1256del (p.Lys418_Pro419delinsAsn) |
deletion |
Inborn genetic diseases [RCV002539470]|Spastic paraplegia [RCV001301448] |
Chr1:228159012..228159014 [GRCh38] Chr1:228346713..228346715 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1084G>A (p.Ala362Thr) |
single nucleotide variant |
Spastic paraplegia [RCV002069535]|not provided [RCV001810641] |
Chr1:228158842 [GRCh38] Chr1:228346543 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NC_000001.10:g.(?_130980840)_(248900000_?)dup |
duplication |
Gastrointestinal stromal tumor [RCV001300221]|Parathyroid carcinoma [RCV001341077] |
Chr1:130980840..248900000 [GRCh37] Chr1:1q12-44 |
uncertain significance |
NM_020435.4(GJC2):c.915G>A (p.Pro305=) |
single nucleotide variant |
Spastic paraplegia [RCV001313721] |
Chr1:228158673 [GRCh38] Chr1:228346374 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NM_020435.4(GJC2):c.519C>T (p.Gly173=) |
single nucleotide variant |
Spastic paraplegia [RCV001369954] |
Chr1:228158277 [GRCh38] Chr1:228345978 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NM_020435.4(GJC2):c.1058T>C (p.Leu353Pro) |
single nucleotide variant |
Spastic paraplegia [RCV001349596] |
Chr1:228158816 [GRCh38] Chr1:228346517 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NC_000001.10:g.(?_228345440)_(228363234_?)dup |
duplication |
Spastic paraplegia [RCV001314891] |
Chr1:228345440..228363234 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1258A>G (p.Arg420Gly) |
single nucleotide variant |
Inborn genetic diseases [RCV002543712]|Spastic paraplegia [RCV001317062] |
Chr1:228159016 [GRCh38] Chr1:228346717 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1208T>C (p.Val403Ala) |
single nucleotide variant |
Inborn genetic diseases [RCV004629564]|Spastic paraplegia [RCV001321080] |
Chr1:228158966 [GRCh38] Chr1:228346667 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1066C>A (p.Gln356Lys) |
single nucleotide variant |
Spastic paraplegia [RCV001299589] |
Chr1:228158824 [GRCh38] Chr1:228346525 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.810T>G (p.Val270=) |
single nucleotide variant |
Spastic paraplegia [RCV001503084] |
Chr1:228158568 [GRCh38] Chr1:228346269 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1057C>T (p.Leu353=) |
single nucleotide variant |
Spastic paraplegia [RCV001456422] |
Chr1:228158815 [GRCh38] Chr1:228346516 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.309C>T (p.Ala103=) |
single nucleotide variant |
Spastic paraplegia [RCV001410985] |
Chr1:228158067 [GRCh38] Chr1:228345768 [GRCh37] Chr1:1q42.13 |
likely benign |
NC_000001.11:g.228149556G>C |
single nucleotide variant |
not provided [RCV001590873] |
Chr1:228149556 [GRCh38] Chr1:228337257 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.993C>G (p.Pro331=) |
single nucleotide variant |
GJC2-related disorder [RCV003938806]|Spastic paraplegia [RCV001451520] |
Chr1:228158751 [GRCh38] Chr1:228346452 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.285G>A (p.Leu95=) |
single nucleotide variant |
GJC2-related disorder [RCV003908827]|Hereditary spastic paraplegia [RCV001847290]|Spastic paraplegia [RCV001514768] |
Chr1:228158043 [GRCh38] Chr1:228345744 [GRCh37] Chr1:1q42.13 |
benign|likely benign|uncertain significance |
NM_020435.4(GJC2):c.486C>T (p.Ala162=) |
single nucleotide variant |
Spastic paraplegia [RCV001478076] |
Chr1:228158244 [GRCh38] Chr1:228345945 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.42G>A (p.Glu14=) |
single nucleotide variant |
Spastic paraplegia [RCV001437360] |
Chr1:228157800 [GRCh38] Chr1:228345501 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.742C>T (p.Gln248Ter) |
single nucleotide variant |
not provided [RCV002247161] |
Chr1:228158500 [GRCh38] Chr1:228346201 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.995delinsCC (p.Asp332fs) |
indel |
not specified [RCV004800834] |
Chr1:228158753 [GRCh38] Chr1:228346454 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.776C>T (p.Ser259Leu) |
single nucleotide variant |
not provided [RCV001762778] |
Chr1:228158534 [GRCh38] Chr1:228346235 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.-19-193C>G |
single nucleotide variant |
not provided [RCV001787603] |
Chr1:228157547 [GRCh38] Chr1:228345248 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.388C>G (p.Pro130Ala) |
single nucleotide variant |
Inborn genetic diseases [RCV004980639]|not provided [RCV001773840] |
Chr1:228158146 [GRCh38] Chr1:228345847 [GRCh37] Chr1:1q42.13 |
uncertain significance |
GRCh37/hg19 1q42.13(chr1:227782268-229506509)x1 |
copy number loss |
not provided [RCV001795846] |
Chr1:227782268..229506509 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.259A>C (p.Ile87Leu) |
single nucleotide variant |
Inborn genetic diseases [RCV004980642]|not provided [RCV001770817] |
Chr1:228158017 [GRCh38] Chr1:228345718 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.310C>T (p.Arg104Cys) |
single nucleotide variant |
not provided [RCV001770842] |
Chr1:228158068 [GRCh38] Chr1:228345769 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.220C>G (p.Leu74Val) |
single nucleotide variant |
not provided [RCV001762768] |
Chr1:228157978 [GRCh38] Chr1:228345679 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.760G>A (p.Val254Met) |
single nucleotide variant |
Abnormality of the nervous system [RCV001814360]|Hypomyelinating leukodystrophy 2 [RCV001849194] |
Chr1:228158518 [GRCh38] Chr1:228346219 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic |
NM_020435.4(GJC2):c.414C>T (p.Pro138=) |
single nucleotide variant |
not provided [RCV001816076] |
Chr1:228158172 [GRCh38] Chr1:228345873 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1137G>A (p.Ala379=) |
single nucleotide variant |
Spastic paraplegia [RCV001926642] |
Chr1:228158895 [GRCh38] Chr1:228346596 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NM_020435.4(GJC2):c.11T>G (p.Met4Arg) |
single nucleotide variant |
Spastic paraplegia [RCV002025920] |
Chr1:228157769 [GRCh38] Chr1:228345470 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.102C>A (p.Phe34Leu) |
single nucleotide variant |
Spastic paraplegia [RCV002041861] |
Chr1:228157860 [GRCh38] Chr1:228345561 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.434A>T (p.Glu145Val) |
single nucleotide variant |
Spastic paraplegia [RCV002041106] |
Chr1:228158192 [GRCh38] Chr1:228345893 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1090G>A (p.Ala364Thr) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001848447]|Spastic paraplegia [RCV002543402] |
Chr1:228158848 [GRCh38] Chr1:228346549 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1191T>C (p.Ala397=) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001848448] |
Chr1:228158949 [GRCh38] Chr1:228346650 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.658A>G (p.Arg220Gly) |
single nucleotide variant |
Spastic paraplegia [RCV001892720] |
Chr1:228158416 [GRCh38] Chr1:228346117 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.472_481dup (p.Ala161fs) |
duplication |
Hypomyelinating leukodystrophy 2 [RCV002052015] |
Chr1:228158228..228158229 [GRCh38] Chr1:228345929..228345930 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.203A>G (p.Tyr68Cys) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV003339863]|Spastic paraplegia [RCV001967075]|not provided [RCV004793662] |
Chr1:228157961 [GRCh38] Chr1:228345662 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.174G>T (p.Thr58=) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001848450] |
Chr1:228157932 [GRCh38] Chr1:228345633 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.127G>A (p.Gly43Ser) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV004691471]|Spastic paraplegia [RCV001965178] |
Chr1:228157885 [GRCh38] Chr1:228345586 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.1219G>A (p.Gly407Ser) |
single nucleotide variant |
Spastic paraplegia [RCV001892616] |
Chr1:228158977 [GRCh38] Chr1:228346678 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.997T>G (p.Tyr333Asp) |
single nucleotide variant |
Spastic paraplegia [RCV001982697] |
Chr1:228158755 [GRCh38] Chr1:228346456 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.*95G>A |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001848445]|not provided [RCV004711734] |
Chr1:228159173 [GRCh38] Chr1:228346874 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1019C>T (p.Ala340Val) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001848446]|Spastic paraplegia [RCV002545271] |
Chr1:228158777 [GRCh38] Chr1:228346478 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1209C>T (p.Val403=) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001848449] |
Chr1:228158967 [GRCh38] Chr1:228346668 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.300C>A (p.His100Gln) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001848451] |
Chr1:228158058 [GRCh38] Chr1:228345759 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.540G>A (p.Lys180=) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001848453] |
Chr1:228158298 [GRCh38] Chr1:228345999 [GRCh37] Chr1:1q42.13 |
uncertain significance |
GRCh37/hg19 1q42.13-42.2(chr1:228214912-231483538) |
copy number loss |
not specified [RCV002052889] |
Chr1:228214912..231483538 [GRCh37] Chr1:1q42.13-42.2 |
pathogenic |
NM_020435.4(GJC2):c.755A>G (p.His252Arg) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV001824214] |
Chr1:228158513 [GRCh38] Chr1:228346214 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.409G>C (p.Glu137Gln) |
single nucleotide variant |
Spastic paraplegia [RCV001925777] |
Chr1:228158167 [GRCh38] Chr1:228345868 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.661G>C (p.Ala221Pro) |
single nucleotide variant |
Spastic paraplegia [RCV001884231] |
Chr1:228158419 [GRCh38] Chr1:228346120 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1088C>A (p.Ala363Glu) |
single nucleotide variant |
Spastic paraplegia [RCV001962034] |
Chr1:228158846 [GRCh38] Chr1:228346547 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1013G>A (p.Arg338Gln) |
single nucleotide variant |
Inborn genetic diseases [RCV003167275]|Spastic paraplegia [RCV001924447]|not provided [RCV004691469] |
Chr1:228158771 [GRCh38] Chr1:228346472 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.545_565dup (p.Val182_Ala188dup) |
duplication |
Spastic paraplegia [RCV001888683] |
Chr1:228158295..228158296 [GRCh38] Chr1:228345996..228345997 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.661G>T (p.Ala221Ser) |
single nucleotide variant |
Spastic paraplegia [RCV001958498] |
Chr1:228158419 [GRCh38] Chr1:228346120 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.498C>T (p.Gly166=) |
single nucleotide variant |
Spastic paraplegia [RCV001919697] |
Chr1:228158256 [GRCh38] Chr1:228345957 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.454GAG[5] (p.Glu157_Glu158del) |
microsatellite |
Spastic paraplegia [RCV001924582] |
Chr1:228158212..228158217 [GRCh38] Chr1:228345913..228345918 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.914_933dup (p.Ala312fs) |
duplication |
Spastic paraplegia [RCV002037972] |
Chr1:228158665..228158666 [GRCh38] Chr1:228346366..228346367 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.516_530dup (p.Gly173_Ala177dup) |
duplication |
Hypomyelinating leukodystrophy 2 [RCV004698354]|Spastic paraplegia [RCV001878556] |
Chr1:228158262..228158263 [GRCh38] Chr1:228345963..228345964 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.343C>T (p.Arg115Cys) |
single nucleotide variant |
Spastic paraplegia [RCV001921283]|not provided [RCV003134244] |
Chr1:228158101 [GRCh38] Chr1:228345802 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.328C>G (p.Arg110Gly) |
single nucleotide variant |
Spastic paraplegia [RCV001934018] |
Chr1:228158086 [GRCh38] Chr1:228345787 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1141_1151del (p.Ser381fs) |
deletion |
Hereditary spastic paraplegia 44 [RCV003227526]|Spastic paraplegia [RCV001902187] |
Chr1:228158895..228158905 [GRCh38] Chr1:228346596..228346606 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.653T>C (p.Val218Ala) |
single nucleotide variant |
Spastic paraplegia [RCV001974512] |
Chr1:228158411 [GRCh38] Chr1:228346112 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1038T>A (p.His346Gln) |
single nucleotide variant |
Inborn genetic diseases [RCV002548047]|Spastic paraplegia [RCV001932104] |
Chr1:228158796 [GRCh38] Chr1:228346497 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NC_000001.10:g.(?_228194830)_(228566496_?)dup |
duplication |
Multiple mitochondrial dysfunctions syndrome 3 [RCV001943243]|not provided [RCV001919147] |
Chr1:228194830..228566496 [GRCh37] Chr1:1q42.13 |
uncertain significance|no classifications from unflagged records |
NM_020435.4(GJC2):c.546_566dup (p.Ala184_Gly190dup) |
duplication |
Spastic paraplegia [RCV002027473] |
Chr1:228158303..228158304 [GRCh38] Chr1:228346004..228346005 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.109G>A (p.Val37Met) |
single nucleotide variant |
Spastic paraplegia [RCV001952486] |
Chr1:228157867 [GRCh38] Chr1:228345568 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.96G>A (p.Val32=) |
single nucleotide variant |
Spastic paraplegia [RCV001905511] |
Chr1:228157854 [GRCh38] Chr1:228345555 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NM_020435.4(GJC2):c.752C>T (p.Pro251Leu) |
single nucleotide variant |
Spastic paraplegia [RCV001935734] |
Chr1:228158510 [GRCh38] Chr1:228346211 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.633C>T (p.Arg211=) |
single nucleotide variant |
Spastic paraplegia [RCV001979825] |
Chr1:228158391 [GRCh38] Chr1:228346092 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NM_020435.4(GJC2):c.539A>G (p.Lys180Arg) |
single nucleotide variant |
Spastic paraplegia [RCV002027938] |
Chr1:228158297 [GRCh38] Chr1:228345998 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.295G>A (p.Val99Met) |
single nucleotide variant |
Spastic paraplegia [RCV001939898] |
Chr1:228158053 [GRCh38] Chr1:228345754 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.35T>C (p.Leu12Pro) |
single nucleotide variant |
Spastic paraplegia [RCV001939227] |
Chr1:228157793 [GRCh38] Chr1:228345494 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.426C>T (p.Gly142=) |
single nucleotide variant |
Spastic paraplegia [RCV001935828] |
Chr1:228158184 [GRCh38] Chr1:228345885 [GRCh37] Chr1:1q42.13 |
likely benign|uncertain significance |
NM_020435.4(GJC2):c.303C>T (p.Arg101=) |
single nucleotide variant |
Spastic paraplegia [RCV002109695] |
Chr1:228158061 [GRCh38] Chr1:228345762 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.765C>T (p.Asp255=) |
single nucleotide variant |
Spastic paraplegia [RCV002147286] |
Chr1:228158523 [GRCh38] Chr1:228346224 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.117G>C (p.Thr39=) |
single nucleotide variant |
Spastic paraplegia [RCV002206131] |
Chr1:228157875 [GRCh38] Chr1:228345576 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1158A>G (p.Arg386=) |
single nucleotide variant |
Spastic paraplegia [RCV002164860] |
Chr1:228158916 [GRCh38] Chr1:228346617 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.543G>T (p.Ala181=) |
single nucleotide variant |
Spastic paraplegia [RCV002168574] |
Chr1:228158301 [GRCh38] Chr1:228346002 [GRCh37] Chr1:1q42.13 |
benign |
NM_020435.4(GJC2):c.561G>A (p.Lys187=) |
single nucleotide variant |
Spastic paraplegia [RCV002095529] |
Chr1:228158319 [GRCh38] Chr1:228346020 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.84C>A (p.Leu28=) |
single nucleotide variant |
Spastic paraplegia [RCV002212688] |
Chr1:228157842 [GRCh38] Chr1:228345543 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.27G>C (p.Leu9=) |
single nucleotide variant |
Spastic paraplegia [RCV002150093] |
Chr1:228157785 [GRCh38] Chr1:228345486 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.-19-39_-19-23del |
deletion |
not provided [RCV002245100] |
Chr1:228157701..228157717 [GRCh38] Chr1:228345402..228345418 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.453C>G (p.Gly151=) |
single nucleotide variant |
Spastic paraplegia [RCV002102869] |
Chr1:228158211 [GRCh38] Chr1:228345912 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.408T>C (p.Pro136=) |
single nucleotide variant |
Spastic paraplegia [RCV002098638] |
Chr1:228158166 [GRCh38] Chr1:228345867 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.537T>C (p.Thr179=) |
single nucleotide variant |
Spastic paraplegia [RCV002143645] |
Chr1:228158295 [GRCh38] Chr1:228345996 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.291C>T (p.Tyr97=) |
single nucleotide variant |
Spastic paraplegia [RCV002218949]|not provided [RCV004711771] |
Chr1:228158049 [GRCh38] Chr1:228345750 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.417C>G (p.Ala139=) |
single nucleotide variant |
Spastic paraplegia [RCV002120588] |
Chr1:228158175 [GRCh38] Chr1:228345876 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.795G>T (p.Thr265=) |
single nucleotide variant |
Spastic paraplegia [RCV002157128] |
Chr1:228158553 [GRCh38] Chr1:228346254 [GRCh37] Chr1:1q42.13 |
likely benign |
NC_000001.10:g.(?_228337558)_(228346779_?)dup |
duplication |
Spastic paraplegia [RCV003109702] |
Chr1:228337558..228346779 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.30_31delinsAA (p.Thr10_Arg11=) |
indel |
Spastic paraplegia [RCV003118019] |
Chr1:228157788..228157789 [GRCh38] Chr1:228345489..228345490 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.196G>T (p.Val66Phe) |
single nucleotide variant |
not provided [RCV004790849] |
Chr1:228157954 [GRCh38] Chr1:228345655 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.773T>A (p.Val258Glu) |
single nucleotide variant |
not provided [RCV004790851] |
Chr1:228158531 [GRCh38] Chr1:228346232 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1175C>T (p.Ser392Phe) |
single nucleotide variant |
not provided [RCV004790859] |
Chr1:228158933 [GRCh38] Chr1:228346634 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.512A>C (p.Glu171Ala) |
single nucleotide variant |
Lymphatic malformation 3 [RCV003455764]|not provided [RCV003131017] |
Chr1:228158270 [GRCh38] Chr1:228345971 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.148G>A (p.Glu50Lys) |
single nucleotide variant |
Lymphatic malformation 3 [RCV002267577]|not provided [RCV004774643] |
Chr1:228157906 [GRCh38] Chr1:228345607 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.392dup (p.His132fs) |
duplication |
not provided [RCV002262268] |
Chr1:228158145..228158146 [GRCh38] Chr1:228345846..228345847 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.293C>A (p.Ala98Asp) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV002283998] |
Chr1:228158051 [GRCh38] Chr1:228345752 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.716T>C (p.Val239Ala) |
single nucleotide variant |
Spastic paraplegia [RCV003097747]|not provided [RCV002287991] |
Chr1:228158474 [GRCh38] Chr1:228346175 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
GRCh37/hg19 1q31.3-44(chr1:197867914-249224684)x3 |
copy number gain |
See cases [RCV002287837] |
Chr1:197867914..249224684 [GRCh37] Chr1:1q31.3-44 |
pathogenic |
NM_020435.4(GJC2):c.357dup (p.Pro120fs) |
duplication |
Hypomyelinating leukodystrophy 2 [RCV004691699] |
Chr1:228158111..228158112 [GRCh38] Chr1:228345812..228345813 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.979_983dup (p.Cys329fs) |
duplication |
Hypomyelinating leukodystrophy 2 [RCV004691701] |
Chr1:228158732..228158733 [GRCh38] Chr1:228346433..228346434 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.226C>A (p.His76Asn) |
single nucleotide variant |
Spastic paraplegia [RCV002301322] |
Chr1:228157984 [GRCh38] Chr1:228345685 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.195C>A (p.Asn65Lys) |
single nucleotide variant |
Spastic paraplegia [RCV002296403] |
Chr1:228157953 [GRCh38] Chr1:228345654 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.873G>A (p.Leu291=) |
single nucleotide variant |
Spastic paraplegia [RCV002615171] |
Chr1:228158631 [GRCh38] Chr1:228346332 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.386C>G (p.Pro129Arg) |
single nucleotide variant |
Spastic paraplegia [RCV002948042] |
Chr1:228158144 [GRCh38] Chr1:228345845 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.462G>A (p.Glu154=) |
single nucleotide variant |
Spastic paraplegia [RCV002908944] |
Chr1:228158220 [GRCh38] Chr1:228345921 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.369_370del (p.Arg125fs) |
microsatellite |
Spastic paraplegia [RCV002820147] |
Chr1:228158122..228158123 [GRCh38] Chr1:228345823..228345824 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.556G>A (p.Gly186Ser) |
single nucleotide variant |
Spastic paraplegia [RCV003075252] |
Chr1:228158314 [GRCh38] Chr1:228346015 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.913C>T (p.Pro305Ser) |
single nucleotide variant |
Inborn genetic diseases [RCV002727768] |
Chr1:228158671 [GRCh38] Chr1:228346372 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.765C>G (p.Asp255Glu) |
single nucleotide variant |
Spastic paraplegia [RCV002755964] |
Chr1:228158523 [GRCh38] Chr1:228346224 [GRCh37] Chr1:1q42.13 |
uncertain significance |
GRCh37/hg19 1q41-44(chr1:223972939-249224684)x3 |
copy number gain |
not provided [RCV002475745] |
Chr1:223972939..249224684 [GRCh37] Chr1:1q41-44 |
pathogenic |
NM_020435.4(GJC2):c.1122C>T (p.Cys374=) |
single nucleotide variant |
Spastic paraplegia [RCV002970987] |
Chr1:228158880 [GRCh38] Chr1:228346581 [GRCh37] Chr1:1q42.13 |
likely benign |
GRCh38/hg38 1q32.2-42.13(chr1:228006998-228061271)x2 |
copy number loss |
Orofacial cleft 2 [RCV002481175] |
Chr1:228006998..228061271 [GRCh38] Chr1:1q32.2-42.13 |
association |
NM_020435.4(GJC2):c.924CCCCGC[3] (p.Pro313_Arg314insAlaPro) |
microsatellite |
Spastic paraplegia [RCV002785697] |
Chr1:228158677..228158678 [GRCh38] Chr1:228346378..228346379 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.327G>C (p.Glu109Asp) |
single nucleotide variant |
Inborn genetic diseases [RCV002692188] |
Chr1:228158085 [GRCh38] Chr1:228345786 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.133G>C (p.Ala45Pro) |
single nucleotide variant |
Spastic paraplegia [RCV002975989] |
Chr1:228157891 [GRCh38] Chr1:228345592 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.282C>T (p.Tyr94=) |
single nucleotide variant |
Spastic paraplegia [RCV002659483] |
Chr1:228158040 [GRCh38] Chr1:228345741 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.29C>T (p.Thr10Met) |
single nucleotide variant |
Spastic paraplegia [RCV002637474] |
Chr1:228157787 [GRCh38] Chr1:228345488 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1035G>C (p.Ala345=) |
single nucleotide variant |
Spastic paraplegia [RCV002886027] |
Chr1:228158793 [GRCh38] Chr1:228346494 [GRCh37] Chr1:1q42.13 |
likely benign |
GRCh38/hg38 1q41-44(chr1:223828500-248891309)x3 |
copy number gain |
See cases [RCV000051878] |
Chr1:223828500..248891309 [GRCh38] Chr1:224016202..249185508 [GRCh37] Chr1:222082825..247152131 [NCBI36] Chr1:1q41-44 |
pathogenic |
NM_020435.4(GJC2):c.1234C>T (p.His412Tyr) |
single nucleotide variant |
Hereditary spastic paraplegia [RCV001848882]|Hypomyelinating leukodystrophy 2 [RCV000763840]|Hypomyelinating leukodystrophy 2 [RCV004691246]|Inborn genetic diseases [RCV002528231]|Spastic paraplegia [RCV000633030]|not provided [RCV000513690]|not specified [RCV003323580] |
Chr1:228158992 [GRCh38] Chr1:228346693 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NC_000001.11:g.228149857A>G |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV000128464]|Spastic paraplegia [RCV001849914] |
Chr1:228149857 [GRCh38] Chr1:228337558 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.1123G>A (p.Val375Ile) |
single nucleotide variant |
Spastic paraplegia [RCV002522638]|not provided [RCV000429203] |
Chr1:228158881 [GRCh38] Chr1:228346582 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.141C>G (p.Tyr47Ter) |
single nucleotide variant |
Spastic paraplegia [RCV000633039] |
Chr1:228157899 [GRCh38] Chr1:228345600 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.672G>T (p.Glu224Asp) |
single nucleotide variant |
Inborn genetic diseases [RCV003242390] |
Chr1:228158430 [GRCh38] Chr1:228346131 [GRCh37] Chr1:1q42.13 |
uncertain significance |
GRCh37/hg19 1q41-42.2(chr1:223653722-234591807)x1 |
copy number loss |
not provided [RCV001005180] |
Chr1:223653722..234591807 [GRCh37] Chr1:1q41-42.2 |
pathogenic |
GRCh37/hg19 1q32.2-44(chr1:210152794-249218992)x3 |
copy number gain |
See cases [RCV001194578] |
Chr1:210152794..249218992 [GRCh37] Chr1:1q32.2-44 |
pathogenic |
NM_020435.4(GJC2):c.454GAG[6] (p.Glu158del) |
microsatellite |
GJC2-related disorder [RCV003973020]|Spastic paraplegia [RCV001047776]|not provided [RCV001811598] |
Chr1:228158212..228158214 [GRCh38] Chr1:228345913..228345915 [GRCh37] Chr1:1q42.13 |
benign|likely benign|uncertain significance |
NM_020435.4(GJC2):c.1228G>A (p.Gly410Ser) |
single nucleotide variant |
Inborn genetic diseases [RCV002538678]|Spastic paraplegia [RCV002032686]|not provided [RCV001726787] |
Chr1:228158986 [GRCh38] Chr1:228346687 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.371_392dup (p.His132fs) |
duplication |
Hypomyelinating leukodystrophy 2 [RCV001824213] |
Chr1:228158127..228158128 [GRCh38] Chr1:228345828..228345829 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
GRCh37/hg19 1q42.12-42.2(chr1:226131690-231908227) |
copy number loss |
not specified [RCV002052878] |
Chr1:226131690..231908227 [GRCh37] Chr1:1q42.12-42.2 |
likely pathogenic |
NM_020435.4(GJC2):c.1028C>T (p.Ala343Val) |
single nucleotide variant |
Spastic paraplegia [RCV002046668] |
Chr1:228158786 [GRCh38] Chr1:228346487 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.659G>A (p.Arg220Lys) |
single nucleotide variant |
GJC2-related disorder [RCV003906655]|not provided [RCV003131018] |
Chr1:228158417 [GRCh38] Chr1:228346118 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.947del (p.Pro316fs) |
deletion |
not provided [RCV002262269] |
Chr1:228158701 [GRCh38] Chr1:228346402 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.641T>C (p.Val214Ala) |
single nucleotide variant |
Spastic paraplegia [RCV002730833] |
Chr1:228158399 [GRCh38] Chr1:228346100 [GRCh37] Chr1:1q42.13 |
uncertain significance |
GRCh37/hg19 1q42.13-43(chr1:227992928-236659905)x3 |
copy number gain |
not provided [RCV002475638] |
Chr1:227992928..236659905 [GRCh37] Chr1:1q42.13-43 |
likely pathogenic |
NM_020435.4(GJC2):c.442C>A (p.Leu148Met) |
single nucleotide variant |
Inborn genetic diseases [RCV002950702]|Spastic paraplegia [RCV005099887] |
Chr1:228158200 [GRCh38] Chr1:228345901 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1149G>C (p.Gly383=) |
single nucleotide variant |
Spastic paraplegia [RCV002622460] |
Chr1:228158907 [GRCh38] Chr1:228346608 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1021G>C (p.Glu341Gln) |
single nucleotide variant |
Inborn genetic diseases [RCV002869984] |
Chr1:228158779 [GRCh38] Chr1:228346480 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1045A>C (p.Asn349His) |
single nucleotide variant |
Inborn genetic diseases [RCV002821229] |
Chr1:228158803 [GRCh38] Chr1:228346504 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.919T>G (p.Ser307Ala) |
single nucleotide variant |
Inborn genetic diseases [RCV002692475] |
Chr1:228158677 [GRCh38] Chr1:228346378 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.506C>T (p.Ala169Val) |
single nucleotide variant |
Spastic paraplegia [RCV003053878] |
Chr1:228158264 [GRCh38] Chr1:228345965 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1037A>T (p.His346Leu) |
single nucleotide variant |
Spastic paraplegia [RCV002982193] |
Chr1:228158795 [GRCh38] Chr1:228346496 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.229G>A (p.Val77Met) |
single nucleotide variant |
Inborn genetic diseases [RCV002787818] |
Chr1:228157987 [GRCh38] Chr1:228345688 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1289G>A (p.Ser430Asn) |
single nucleotide variant |
Spastic paraplegia [RCV003025807] |
Chr1:228159047 [GRCh38] Chr1:228346748 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.960C>T (p.Phe320=) |
single nucleotide variant |
Spastic paraplegia [RCV002958702]|not provided [RCV003418665] |
Chr1:228158718 [GRCh38] Chr1:228346419 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.224C>A (p.Ser75Ter) |
single nucleotide variant |
Spastic paraplegia [RCV003026170] |
Chr1:228157982 [GRCh38] Chr1:228345683 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.1151C>A (p.Pro384His) |
single nucleotide variant |
Inborn genetic diseases [RCV002641227]|Spastic paraplegia [RCV005099438] |
Chr1:228158909 [GRCh38] Chr1:228346610 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.84C>T (p.Leu28=) |
single nucleotide variant |
Spastic paraplegia [RCV002928324] |
Chr1:228157842 [GRCh38] Chr1:228345543 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1105C>T (p.Arg369Trp) |
single nucleotide variant |
Spastic paraplegia [RCV003083955] |
Chr1:228158863 [GRCh38] Chr1:228346564 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.496G>A (p.Gly166Ser) |
single nucleotide variant |
Spastic paraplegia [RCV002572692] |
Chr1:228158254 [GRCh38] Chr1:228345955 [GRCh37] Chr1:1q42.13 |
uncertain significance |
GRCh37/hg19 1q42.11-43(chr1:224230307-243181599)x3 |
copy number gain |
not provided [RCV002509019] |
Chr1:224230307..243181599 [GRCh37] Chr1:1q42.11-43 |
not provided |
NM_020435.4(GJC2):c.947C>A (p.Pro316Gln) |
single nucleotide variant |
Spastic paraplegia [RCV002982493] |
Chr1:228158705 [GRCh38] Chr1:228346406 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.968C>T (p.Ala323Val) |
single nucleotide variant |
Spastic paraplegia [RCV002985680] |
Chr1:228158726 [GRCh38] Chr1:228346427 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1229G>A (p.Gly410Asp) |
single nucleotide variant |
Spastic paraplegia [RCV002890205] |
Chr1:228158987 [GRCh38] Chr1:228346688 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.549C>T (p.Gly183=) |
single nucleotide variant |
Spastic paraplegia [RCV002852537] |
Chr1:228158307 [GRCh38] Chr1:228346008 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.902G>C (p.Arg301Pro) |
single nucleotide variant |
Spastic paraplegia [RCV003063282] |
Chr1:228158660 [GRCh38] Chr1:228346361 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.373C>A (p.Arg125=) |
single nucleotide variant |
Spastic paraplegia [RCV003089554] |
Chr1:228158131 [GRCh38] Chr1:228345832 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1133C>T (p.Pro378Leu) |
single nucleotide variant |
Spastic paraplegia [RCV002578724] |
Chr1:228158891 [GRCh38] Chr1:228346592 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.292G>A (p.Ala98Thr) |
single nucleotide variant |
Spastic paraplegia [RCV003062281] |
Chr1:228158050 [GRCh38] Chr1:228345751 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.923C>T (p.Ala308Val) |
single nucleotide variant |
Inborn genetic diseases [RCV004973536]|Spastic paraplegia [RCV002646210] |
Chr1:228158681 [GRCh38] Chr1:228346382 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.139T>C (p.Tyr47His) |
single nucleotide variant |
Inborn genetic diseases [RCV002808049]|Spastic paraplegia [RCV003750936]|not provided [RCV004775322] |
Chr1:228157897 [GRCh38] Chr1:228345598 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.231_233del (p.Arg78del) |
deletion |
Spastic paraplegia [RCV002857601] |
Chr1:228157989..228157991 [GRCh38] Chr1:228345690..228345692 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.914dup (p.Ala306fs) |
duplication |
Lymphatic malformation 3 [RCV003989797]|Spastic paraplegia [RCV003009162] |
Chr1:228158666..228158667 [GRCh38] Chr1:228346367..228346368 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.546C>G (p.Val182=) |
single nucleotide variant |
Spastic paraplegia [RCV002632883] |
Chr1:228158304 [GRCh38] Chr1:228346005 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1056C>G (p.Asn352Lys) |
single nucleotide variant |
Spastic paraplegia [RCV003063896] |
Chr1:228158814 [GRCh38] Chr1:228346515 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.479G>A (p.Gly160Glu) |
single nucleotide variant |
Inborn genetic diseases [RCV002940747]|not provided [RCV004593191] |
Chr1:228158237 [GRCh38] Chr1:228345938 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.530C>T (p.Ala177Val) |
single nucleotide variant |
Inborn genetic diseases [RCV003088185]|Spastic paraplegia [RCV003088186] |
Chr1:228158288 [GRCh38] Chr1:228345989 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.649_651del (p.Leu217del) |
deletion |
Spastic paraplegia [RCV002814526] |
Chr1:228158406..228158408 [GRCh38] Chr1:228346107..228346109 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.898G>A (p.Gly300Ser) |
single nucleotide variant |
Spastic paraplegia [RCV003070004] |
Chr1:228158656 [GRCh38] Chr1:228346357 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.-20+1G>C |
single nucleotide variant |
Spastic paraplegia [RCV002634353] |
Chr1:228150008 [GRCh38] Chr1:228337709 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.32G>A (p.Arg11Gln) |
single nucleotide variant |
Inborn genetic diseases [RCV004978728]|Spastic paraplegia [RCV002654621] |
Chr1:228157790 [GRCh38] Chr1:228345491 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.601C>T (p.Arg201Trp) |
single nucleotide variant |
Spastic paraplegia [RCV003070244] |
Chr1:228158359 [GRCh38] Chr1:228346060 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1195T>C (p.Ser399Pro) |
single nucleotide variant |
Spastic paraplegia [RCV002587868] |
Chr1:228158953 [GRCh38] Chr1:228346654 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.721C>T (p.Pro241Ser) |
single nucleotide variant |
Spastic paraplegia [RCV003069465] |
Chr1:228158479 [GRCh38] Chr1:228346180 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1191T>A (p.Ala397=) |
single nucleotide variant |
Spastic paraplegia [RCV002680772] |
Chr1:228158949 [GRCh38] Chr1:228346650 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.393G>A (p.Pro131=) |
single nucleotide variant |
Spastic paraplegia [RCV003066929] |
Chr1:228158151 [GRCh38] Chr1:228345852 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.407C>G (p.Pro136Arg) |
single nucleotide variant |
Spastic paraplegia [RCV002612645] |
Chr1:228158165 [GRCh38] Chr1:228345866 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1144C>T (p.Arg382Trp) |
single nucleotide variant |
Inborn genetic diseases [RCV003206234] |
Chr1:228158902 [GRCh38] Chr1:228346603 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.820G>C (p.Val274Leu) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV004527454]|not provided [RCV003222658] |
Chr1:228158578 [GRCh38] Chr1:228346279 [GRCh37] Chr1:1q42.13 |
likely pathogenic|uncertain significance |
NM_020435.4(GJC2):c.830T>C (p.Leu277Pro) |
single nucleotide variant |
Spastic paraplegia [RCV003750940]|not provided [RCV003135367] |
Chr1:228158588 [GRCh38] Chr1:228346289 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.934G>T (p.Ala312Ser) |
single nucleotide variant |
Inborn genetic diseases [RCV003204959] |
Chr1:228158692 [GRCh38] Chr1:228346393 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.190G>A (p.Asp64Asn) |
single nucleotide variant |
Inborn genetic diseases [RCV003214256] |
Chr1:228157948 [GRCh38] Chr1:228345649 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.916_928dup (p.Ala310fs) |
duplication |
Hypomyelinating leukodystrophy 2 [RCV004691694] |
Chr1:228158667..228158668 [GRCh38] Chr1:228346368..228346369 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.746C>T (p.Pro249Leu) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV004691696] |
Chr1:228158504 [GRCh38] Chr1:228346205 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.814T>C (p.Tyr272His) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV003340989] |
Chr1:228158572 [GRCh38] Chr1:228346273 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.32G>C (p.Arg11Pro) |
single nucleotide variant |
Lymphatic malformation 3 [RCV003448739] |
Chr1:228157790 [GRCh38] Chr1:228345491 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.607C>T (p.Arg203Cys) |
single nucleotide variant |
Lymphatic malformation 3 [RCV003455873] |
Chr1:228158365 [GRCh38] Chr1:228346066 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.644C>T (p.Ala215Val) |
single nucleotide variant |
Spastic paraplegia [RCV003874058] |
Chr1:228158402 [GRCh38] Chr1:228346103 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.704A>G (p.Tyr235Cys) |
single nucleotide variant |
Spastic paraplegia [RCV003872883] |
Chr1:228158462 [GRCh38] Chr1:228346163 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.706G>C (p.Gly236Arg) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV003484509] |
Chr1:228158464 [GRCh38] Chr1:228346165 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.965C>A (p.Ala322Glu) |
single nucleotide variant |
Inborn genetic diseases [RCV004978886]|not provided [RCV003481588] |
Chr1:228158723 [GRCh38] Chr1:228346424 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.357G>T (p.Gly119=) |
single nucleotide variant |
Spastic paraplegia [RCV003882084] |
Chr1:228158115 [GRCh38] Chr1:228345816 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.452G>T (p.Gly151Val) |
single nucleotide variant |
Spastic paraplegia [RCV003750712] |
Chr1:228158210 [GRCh38] Chr1:228345911 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.453C>T (p.Gly151=) |
single nucleotide variant |
Spastic paraplegia [RCV003750713] |
Chr1:228158211 [GRCh38] Chr1:228345912 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.372C>G (p.Pro124=) |
single nucleotide variant |
Spastic paraplegia [RCV003751212] |
Chr1:228158130 [GRCh38] Chr1:228345831 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1128C>A (p.Gly376=) |
single nucleotide variant |
Spastic paraplegia [RCV003751494] |
Chr1:228158886 [GRCh38] Chr1:228346587 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.784A>C (p.Thr262Pro) |
single nucleotide variant |
Spastic paraplegia [RCV003751496]|not provided [RCV005220761] |
Chr1:228158542 [GRCh38] Chr1:228346243 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.484G>A (p.Ala162Thr) |
single nucleotide variant |
Spastic paraplegia [RCV003750758] |
Chr1:228158242 [GRCh38] Chr1:228345943 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.584C>T (p.Thr195Ile) |
single nucleotide variant |
Spastic paraplegia [RCV003751282] |
Chr1:228158342 [GRCh38] Chr1:228346043 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.412C>A (p.Pro138Thr) |
single nucleotide variant |
Spastic paraplegia [RCV003751808] |
Chr1:228158170 [GRCh38] Chr1:228345871 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.975T>G (p.Ala325=) |
single nucleotide variant |
Spastic paraplegia [RCV003751943] |
Chr1:228158733 [GRCh38] Chr1:228346434 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.338C>T (p.Ala113Val) |
single nucleotide variant |
Spastic paraplegia [RCV003751872] |
Chr1:228158096 [GRCh38] Chr1:228345797 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.577G>T (p.Gly193Cys) |
single nucleotide variant |
Spastic paraplegia [RCV003750709] |
Chr1:228158335 [GRCh38] Chr1:228346036 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.636G>C (p.Val212=) |
single nucleotide variant |
Spastic paraplegia [RCV003751746] |
Chr1:228158394 [GRCh38] Chr1:228346095 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.766T>C (p.Cys256Arg) |
single nucleotide variant |
Spastic paraplegia [RCV003752348] |
Chr1:228158524 [GRCh38] Chr1:228346225 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.902_910dup (p.Gly303_Pro304insArgArgGly) |
duplication |
Spastic paraplegia [RCV003751851] |
Chr1:228158652..228158653 [GRCh38] Chr1:228346353..228346354 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.678C>T (p.Ala226=) |
single nucleotide variant |
Spastic paraplegia [RCV003752082] |
Chr1:228158436 [GRCh38] Chr1:228346137 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.51C>T (p.His17=) |
single nucleotide variant |
GJC2-related disorder [RCV003956541]|Spastic paraplegia [RCV003751393] |
Chr1:228157809 [GRCh38] Chr1:228345510 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.637T>A (p.Tyr213Asn) |
single nucleotide variant |
Spastic paraplegia [RCV003751658]|not provided [RCV004775459] |
Chr1:228158395 [GRCh38] Chr1:228346096 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.69_82dup (p.Leu28fs) |
duplication |
Spastic paraplegia [RCV003588128] |
Chr1:228157826..228157827 [GRCh38] Chr1:228345527..228345528 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.1013G>T (p.Arg338Leu) |
single nucleotide variant |
Spastic paraplegia [RCV003820376] |
Chr1:228158771 [GRCh38] Chr1:228346472 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.782C>G (p.Pro261Arg) |
single nucleotide variant |
Spastic paraplegia [RCV003589346] |
Chr1:228158540 [GRCh38] Chr1:228346241 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.363C>G (p.Arg121=) |
single nucleotide variant |
Spastic paraplegia [RCV003588096] |
Chr1:228158121 [GRCh38] Chr1:228345822 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1050G>A (p.Leu350=) |
single nucleotide variant |
Spastic paraplegia [RCV003590320] |
Chr1:228158808 [GRCh38] Chr1:228346509 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.751C>G (p.Pro251Ala) |
single nucleotide variant |
Spastic paraplegia [RCV003589397] |
Chr1:228158509 [GRCh38] Chr1:228346210 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.368C>A (p.Ala123Glu) |
single nucleotide variant |
Spastic paraplegia [RCV003588368] |
Chr1:228158126 [GRCh38] Chr1:228345827 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1092T>A (p.Ala364=) |
single nucleotide variant |
Spastic paraplegia [RCV003842806] |
Chr1:228158850 [GRCh38] Chr1:228346551 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.251T>C (p.Ile84Thr) |
single nucleotide variant |
Spastic paraplegia [RCV003588095] |
Chr1:228158009 [GRCh38] Chr1:228345710 [GRCh37] Chr1:1q42.13 |
uncertain significance |
GRCh37/hg19 1q42.13(chr1:228215364-229747702)x1 |
copy number loss |
not specified [RCV003986606] |
Chr1:228215364..229747702 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.177G>T (p.Arg59=) |
single nucleotide variant |
Spastic paraplegia [RCV003588391] |
Chr1:228157935 [GRCh38] Chr1:228345636 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1125C>T (p.Val375=) |
single nucleotide variant |
Spastic paraplegia [RCV003588385] |
Chr1:228158883 [GRCh38] Chr1:228346584 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.608G>A (p.Arg203His) |
single nucleotide variant |
Spastic paraplegia [RCV003590765] |
Chr1:228158366 [GRCh38] Chr1:228346067 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1249G>C (p.Ala417Pro) |
single nucleotide variant |
Spastic paraplegia [RCV003588303] |
Chr1:228159007 [GRCh38] Chr1:228346708 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.126C>T (p.Gly42=) |
single nucleotide variant |
Spastic paraplegia [RCV003590060] |
Chr1:228157884 [GRCh38] Chr1:228345585 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.175C>A (p.Arg59=) |
single nucleotide variant |
GJC2-related disorder [RCV004758279]|Spastic paraplegia [RCV003589064] |
Chr1:228157933 [GRCh38] Chr1:228345634 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.909C>A (p.Gly303=) |
single nucleotide variant |
not provided [RCV003993275] |
Chr1:228158667 [GRCh38] Chr1:228346368 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.619G>A (p.Glu207Lys) |
single nucleotide variant |
Lymphatic malformation 3 [RCV003989192]|not provided [RCV004812510] |
Chr1:228158377 [GRCh38] Chr1:228346078 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.104G>A (p.Arg35His) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV003985010] |
Chr1:228157862 [GRCh38] Chr1:228345563 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.360A>G (p.Pro120=) |
single nucleotide variant |
GJC2-related disorder [RCV003961711] |
Chr1:228158118 [GRCh38] Chr1:228345819 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.693G>T (p.Gln231His) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV004691693] |
Chr1:228158451 [GRCh38] Chr1:228346152 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.790A>T (p.Lys264Ter) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV004691697] |
Chr1:228158548 [GRCh38] Chr1:228346249 [GRCh37] Chr1:1q42.13 |
pathogenic |
NC_000001.10:g.(?_228194830)_(228566496_?)del |
deletion |
Multiple mitochondrial dysfunctions syndrome 3 [RCV004583928]|Spastic paraplegia [RCV004583927] |
Chr1:228194830..228566496 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.176G>C (p.Arg59Pro) |
single nucleotide variant |
Inborn genetic diseases [RCV004627141] |
Chr1:228157934 [GRCh38] Chr1:228345635 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.575C>T (p.Pro192Leu) |
single nucleotide variant |
Inborn genetic diseases [RCV004627142] |
Chr1:228158333 [GRCh38] Chr1:228346034 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.706G>A (p.Gly236Ser) |
single nucleotide variant |
not provided [RCV004697649] |
Chr1:228158464 [GRCh38] Chr1:228346165 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.196_201del (p.Val66_Cys67del) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV004691695] |
Chr1:228157953..228157958 [GRCh38] Chr1:228345654..228345659 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.99del (p.Phe34fs) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV004691698] |
Chr1:228157857 [GRCh38] Chr1:228345558 [GRCh37] Chr1:1q42.13 |
likely pathogenic |
NM_020435.4(GJC2):c.282C>G (p.Tyr94Ter) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV004698399] |
Chr1:228158040 [GRCh38] Chr1:228345741 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.184G>C (p.Gly62Arg) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV004586412] |
Chr1:228157942 [GRCh38] Chr1:228345643 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.401del (p.Gly134fs) |
deletion |
Lymphatic malformation 3 [RCV004764652] |
Chr1:228158158 [GRCh38] Chr1:228345859 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.392del (p.Pro131fs) |
deletion |
Spastic paraplegia [RCV005104959]|not provided [RCV004771274] |
Chr1:228158146 [GRCh38] Chr1:228345847 [GRCh37] Chr1:1q42.13 |
pathogenic|likely pathogenic |
NM_020435.4(GJC2):c.483_492del (p.Ala162fs) |
deletion |
Hypomyelinating leukodystrophy 2 [RCV004764322] |
|
likely pathogenic |
NM_020435.4(GJC2):c.*5G>A |
single nucleotide variant |
GJC2-related disorder [RCV004758468] |
Chr1:228159083 [GRCh38] Chr1:228346784 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1150C>A (p.Pro384Thr) |
single nucleotide variant |
not provided [RCV004772049] |
Chr1:228158908 [GRCh38] Chr1:228346609 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1162G>C (p.Gly388Arg) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV005009819] |
Chr1:228158920 [GRCh38] Chr1:228346621 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.373C>G (p.Arg125Gly) |
single nucleotide variant |
Lymphatic malformation 3 [RCV005052228] |
Chr1:228158131 [GRCh38] Chr1:228345832 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.314C>T (p.Ala105Val) |
single nucleotide variant |
Inborn genetic diseases [RCV004982554] |
Chr1:228158072 [GRCh38] Chr1:228345773 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.927C>T (p.Pro309=) |
single nucleotide variant |
Spastic paraplegia [RCV005173038] |
Chr1:228158685 [GRCh38] Chr1:228346386 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.532T>A (p.Cys178Ser) |
single nucleotide variant |
Spastic paraplegia [RCV005082315] |
Chr1:228158290 [GRCh38] Chr1:228345991 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.145del (p.Asp49fs) |
deletion |
Spastic paraplegia [RCV005149026] |
Chr1:228157902 [GRCh38] Chr1:228345603 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.1302G>A (p.Lys434=) |
single nucleotide variant |
Spastic paraplegia [RCV005202531] |
Chr1:228159060 [GRCh38] Chr1:228346761 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.985T>C (p.Cys329Arg) |
single nucleotide variant |
Spastic paraplegia [RCV005079635] |
Chr1:228158743 [GRCh38] Chr1:228346444 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.20_21delinsTT (p.Ser7Ile) |
indel |
Spastic paraplegia [RCV005081104] |
Chr1:228157778..228157779 [GRCh38] Chr1:228345479..228345480 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1023G>C (p.Glu341Asp) |
single nucleotide variant |
Spastic paraplegia [RCV005189807] |
Chr1:228158781 [GRCh38] Chr1:228346482 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.562del (p.Ala188fs) |
deletion |
Spastic paraplegia [RCV005116753] |
Chr1:228158319 [GRCh38] Chr1:228346020 [GRCh37] Chr1:1q42.13 |
pathogenic |
NM_020435.4(GJC2):c.672G>A (p.Glu224=) |
single nucleotide variant |
Spastic paraplegia [RCV005182649] |
Chr1:228158430 [GRCh38] Chr1:228346131 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.346C>A (p.Arg116Ser) |
single nucleotide variant |
Spastic paraplegia [RCV005134475] |
Chr1:228158104 [GRCh38] Chr1:228345805 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.195C>T (p.Asn65=) |
single nucleotide variant |
Spastic paraplegia [RCV005144788] |
Chr1:228157953 [GRCh38] Chr1:228345654 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1111A>T (p.Ser371Cys) |
single nucleotide variant |
Spastic paraplegia [RCV005144832] |
Chr1:228158869 [GRCh38] Chr1:228346570 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.367G>T (p.Ala123Ser) |
single nucleotide variant |
Spastic paraplegia [RCV005197641] |
Chr1:228158125 [GRCh38] Chr1:228345826 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.757G>A (p.Val253Met) |
single nucleotide variant |
Spastic paraplegia [RCV005155253] |
Chr1:228158515 [GRCh38] Chr1:228346216 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.473A>G (p.Glu158Gly) |
single nucleotide variant |
Spastic paraplegia [RCV005180299] |
Chr1:228158231 [GRCh38] Chr1:228345932 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1035G>A (p.Ala345=) |
single nucleotide variant |
Spastic paraplegia [RCV005177601] |
Chr1:228158793 [GRCh38] Chr1:228346494 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.1154C>T (p.Pro385Leu) |
single nucleotide variant |
Inborn genetic diseases [RCV004982556] |
Chr1:228158912 [GRCh38] Chr1:228346613 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.897C>T (p.Arg299=) |
single nucleotide variant |
Spastic paraplegia [RCV002814604] |
Chr1:228158655 [GRCh38] Chr1:228346356 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.750C>G (p.Cys250Trp) |
single nucleotide variant |
not provided [RCV004778306] |
Chr1:228158508 [GRCh38] Chr1:228346209 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.400G>A (p.Gly134Ser) |
single nucleotide variant |
Hypomyelinating leukodystrophy 2 [RCV005011233]|Inborn genetic diseases [RCV003162195]|Spastic paraplegia [RCV003588863]|not provided [RCV003135369] |
Chr1:228158158 [GRCh38] Chr1:228345859 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.988C>T (p.Pro330Ser) |
single nucleotide variant |
not provided [RCV003414856] |
Chr1:228158746 [GRCh38] Chr1:228346447 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1147G>A (p.Gly383Arg) |
single nucleotide variant |
Spastic paraplegia [RCV005084884] |
Chr1:228158905 [GRCh38] Chr1:228346606 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.86C>T (p.Thr29Met) |
single nucleotide variant |
Inborn genetic diseases [RCV004390820] |
Chr1:228157844 [GRCh38] Chr1:228345545 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.1177C>G (p.Arg393Gly) |
single nucleotide variant |
Inborn genetic diseases [RCV004390815] |
Chr1:228158935 [GRCh38] Chr1:228346636 [GRCh37] Chr1:1q42.13 |
likely benign |
NM_020435.4(GJC2):c.175C>T (p.Arg59Trp) |
single nucleotide variant |
Inborn genetic diseases [RCV004390816] |
Chr1:228157933 [GRCh38] Chr1:228345634 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.370C>T (p.Pro124Ser) |
single nucleotide variant |
Inborn genetic diseases [RCV004390817] |
Chr1:228158128 [GRCh38] Chr1:228345829 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.440T>C (p.Met147Thr) |
single nucleotide variant |
Inborn genetic diseases [RCV004390819] |
Chr1:228158198 [GRCh38] Chr1:228345899 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.405G>T (p.Trp135Cys) |
single nucleotide variant |
Inborn genetic diseases [RCV004390818] |
Chr1:228158163 [GRCh38] Chr1:228345864 [GRCh37] Chr1:1q42.13 |
uncertain significance |
NM_020435.4(GJC2):c.155C>T (p.Ala52Val) |
single nucleotide variant |
not provided [RCV004762551] |
|
uncertain significance |
NM_020435.4(GJC2):c.1274A>G (p.Lys425Arg) |
single nucleotide variant |
Inborn genetic diseases [RCV004982555] |
Chr1:228159032 [GRCh38] Chr1:228346733 [GRCh37] Chr1:1q42.13 |
uncertain significance |